Related Experiment Video
Updated: Jun 1, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
"Zeus" a new oral anticoagulant therapy dosing algorithm: a cohort study
A Cafolla1, R Melizzi, E Baldacci
1Dipartimento di Biotecnologie Cellulari ed Ematologia, Sapienza Università Roma, Italy. cafolla@bce.uniroma1.it
The Zeus algorithm significantly improved oral anticoagulant therapy (OAT) management. It increased time in therapeutic range (TTR) and reduced clinical events compared to manual dosing.
Area of Science:
- Pharmacology and Therapeutics
- Medical Informatics
Background:
- Oral anticoagulant therapy (OAT) demand has risen, with increasing use of computer assistance.
- Mathematical algorithms are developed to guide OAT dosing and follow-up.
- Expert physicians manually manage OAT based on International Normalized Ratio (INR) targets.
Purpose of the Study:
- To evaluate the efficacy and safety of a new algorithm, "Zeus", for OAT dosing.
- To compare Zeus algorithm dosing against manual dosing by expert physicians.
- To assess improvements in therapy quality, efficiency, and safety.
Main Methods:
- A before-after study design was employed.
- Data from 1876 patients were analyzed, with each patient managed under both modalities for eight months.
- The study compared algorithm-assisted dosing versus physician-determined manual dosing.
Main Results:
- Time in therapeutic range (TTR) was significantly higher with Zeus (62.3%) versus manual dosing (50.3%).
- Algorithm-guided prescriptions significantly reduced PT/INR tests above 5 and the total anticoagulant drug amount.
- Fewer clinical events were observed in patients managed with the Zeus algorithm.
Conclusions:
- The Zeus algorithm demonstrates significant clinical utility in computer-assisted OAT.
- The algorithm proves to be an effective and safe method for managing OAT.
- Computer-assisted OAT, particularly with the Zeus algorithm, enhances therapeutic outcomes.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Drug Dosing: Obese Patients
Dosage Regimens: Designs and Approaches
Drug Dosing: Geriatric Patients
